Literature DB >> 30226136

Socioeconomic Factors Associated with Fasciola hepatica Infection Among Children from 26 Communities of the Cusco Region of Peru.

Miguel M Cabada1,2, Maria Luisa Morales1, Camille M Webb2, Logan Yang3, Chelsey A Bravenec3, Martha Lopez1, Ruben Bascope4, A Clinton White2, Eduardo Gotuzzo1.   

Abstract

Fasciola hepatica is the most widely distributed trematode-affecting humans. The Andes Mountains are highly endemic for fascioliasis. We report results of a cross-sectional study evaluating the epidemiology of Fasciola among children in 26 agricultural communities in the Cusco region of Peru. Children 3 to 16 years old were enrolled in preschools and schools. Blood from participants was tested for complete blood counts, transaminases, and Fasciola antibodies. Stool samples were tested for Fasciola and other parasites. A total of 2,515 children were included in the analysis and the mean age was 9.6 years (±3.6). Ten percent (253) of the children had at least one positive test for Fasciola, 6% had chronic infection, and 0.4% acute infection. The rest of the subjects had only antibodies against Fasciola. The prevalence of infection varied from 0% to 20% between communities. Children with evidence of Fasciola exposure were older, lived at higher altitudes, and had a lower socioeconomic status than children without infection. The logistic regression analysis showed that children from Ancahuasi district, older children, and children with higher measures of poverty were more likely to have Fasciola exposure. Fascioliasis is common in the Cusco region and associated with poverty. However, the distribution varies markedly between communities.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30226136      PMCID: PMC6221222          DOI: 10.4269/ajtmh.18-0372

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  24 in total

1.  Burden of Fasciola hepatica Infection among children from Paucartambo in Cusco, Peru.

Authors:  Martha Lopez; A Clinton White; Miguel M Cabada
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

Review 2.  Controversial aspects of the life cycle of Fasciola hepatica.

Authors:  Mohammad Moazeni; Amin Ahmadi
Journal:  Exp Parasitol       Date:  2016-07-28       Impact factor: 2.011

Review 3.  Global burden of human food-borne trematodiasis: a systematic review and meta-analysis.

Authors:  Thomas Fürst; Jennifer Keiser; Jürg Utzinger
Journal:  Lancet Infect Dis       Date:  2011-11-20       Impact factor: 25.071

4.  The Northern Bolivian Altiplano: a region highly endemic for human fascioliasis.

Authors:  S Mas-Coma; R Anglés; J G Esteban; M D Bargues; P Buchon; M Franken; W Strauss
Journal:  Trop Med Int Health       Date:  1999-06       Impact factor: 2.622

5.  High fascioliasis infection in children linked to a man-made irrigation zone in Peru.

Authors:  J Guillermo Esteban; Carolina González; M Dolores Bargues; René Angles; Clemente Sánchez; César Náquira; Santiago Mas-Coma
Journal:  Trop Med Int Health       Date:  2002-04       Impact factor: 2.622

Review 6.  Epidemiology of human fascioliasis: a review and proposed new classification.

Authors:  M S Mas-Coma; J G Esteban; M D Bargues
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

7.  Fasciola hepatica and lymnaeid snails occurring at very high altitude in South America.

Authors:  S Mas-Coma; I R Funatsu; M D Bargues
Journal:  Parasitology       Date:  2001       Impact factor: 3.234

8.  Fascioliasis and eosinophilia in the highlands of Cuzco, Peru and their association with water and socioeconomic factors.

Authors:  Miguel M Cabada; Mary R Goodrich; Brittany Graham; Pablo G Villanueva-Meyer; Martha Lopez; Eulogia Arque; A Clinton White
Journal:  Am J Trop Med Hyg       Date:  2014-09-08       Impact factor: 2.345

Review 9.  Fascioliasis: a worldwide parasitic disease of importance in travel medicine.

Authors:  Keyhan Ashrafi; M Dolores Bargues; Sandra O'Neill; Santiago Mas-Coma
Journal:  Travel Med Infect Dis       Date:  2014-09-28       Impact factor: 6.211

10.  Seroprevalence of Human Fasciolosis in Lorestan Province, Western Iran, in 2015-16.

Authors:  Peyman Heydarian; Keyhan Ashrafi; Mehdi Mohebali; Eshrat Beigom Kia; Mojgan Aryaeipour; Ali Chegeni Sharafi; Hamid Mokhayeri; Arezoo Bozorgomid; Mohammad Bagher Rokni
Journal:  Iran J Parasitol       Date:  2017 Jul-Sep       Impact factor: 1.012

View more
  5 in total

1.  The Differences in the Susceptibility Patterns to Triclabendazole Sulfoxide in Field Isolates of Fasciola hepatica Are Associated with Geographic, Seasonal, and Morphometric Variations.

Authors:  Martha V Fernandez-Baca; Cristian Hoban; Rodrigo A Ore; Pedro Ortiz; Young-Jun Choi; César Murga-Moreno; Makedonka Mitreva; Miguel M Cabada
Journal:  Pathogens       Date:  2022-05-28

2.  Geospatial analysis of the associations between environmental contamination with livestock feces and children with chronic fascioliasis in the Anta province of Cusco, Peru.

Authors:  Melinda Barbara Tanabe; John Prochaska; Maria Luisa Morales; Martha Lopez; Benicia Baca-Turpo; Eulogia Arque; Miguel Mauricio Cabada
Journal:  PLoS Negl Trop Dis       Date:  2022-06-16

3.  Economic impact of the liver condemnation of cattle infected with Fasciola hepatica in the Peruvian Andes.

Authors:  Carmen Arias-Pacheco; J Raúl Lucas; Alejandro Rodríguez; Daniela Córdoba; Estevam G Lux-Hoppe
Journal:  Trop Anim Health Prod       Date:  2020-01-22       Impact factor: 1.559

Review 4.  Human Fascioliasis: Current Epidemiological Status and Strategies for Diagnosis, Treatment, and Control.

Authors:  Maria Alejandra Caravedo; Miguel Mauricio Cabada
Journal:  Res Rep Trop Med       Date:  2020-11-26

5.  Stunting in pre-school and school-age children in the Peruvian highlands and its association with Fasciola infection and demographic factors.

Authors:  Camille M Webb; Maria Luisa Morales; Martha Lopez; Benicia Baca-Turpo; Eulogia Arque; A Clinton White; Miguel M Cabada
Journal:  PLoS Negl Trop Dis       Date:  2021-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.